These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 25866058)
1. Microphthalmia-associated transcription factor expression levels in melanoma cells contribute to cell invasion and proliferation. Vachtenheim J; Ondrušová L Exp Dermatol; 2015 Jul; 24(7):481-4. PubMed ID: 25866058 [TBL] [Abstract][Full Text] [Related]
2. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells. Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332 [TBL] [Abstract][Full Text] [Related]
3. Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells. Goodall J; Carreira S; Denat L; Kobi D; Davidson I; Nuciforo P; Sturm RA; Larue L; Goding CR Cancer Res; 2008 Oct; 68(19):7788-94. PubMed ID: 18829533 [TBL] [Abstract][Full Text] [Related]
4. Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor. Boyle GM; Woods SL; Bonazzi VF; Stark MS; Hacker E; Aoude LG; Dutton-Regester K; Cook AL; Sturm RA; Hayward NK Pigment Cell Melanoma Res; 2011 Jun; 24(3):525-37. PubMed ID: 21435193 [TBL] [Abstract][Full Text] [Related]
5. MITF and BRN2 contribute to metastatic growth after dissemination of melanoma. Simmons JL; Pierce CJ; Al-Ejeh F; Boyle GM Sci Rep; 2017 Sep; 7(1):10909. PubMed ID: 28883623 [TBL] [Abstract][Full Text] [Related]
6. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Carreira S; Goodall J; Denat L; Rodriguez M; Nuciforo P; Hoek KS; Testori A; Larue L; Goding CR Genes Dev; 2006 Dec; 20(24):3426-39. PubMed ID: 17182868 [TBL] [Abstract][Full Text] [Related]
7. The three M's: melanoma, microphthalmia-associated transcription factor and microRNA. Bell RE; Levy C Pigment Cell Melanoma Res; 2011 Dec; 24(6):1088-106. PubMed ID: 22004179 [TBL] [Abstract][Full Text] [Related]
8. NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF. Fane ME; Chhabra Y; Hollingsworth DEJ; Simmons JL; Spoerri L; Oh TG; Chauhan J; Chin T; Harris L; Harvey TJ; Muscat GEO; Goding CR; Sturm RA; Haass NK; Boyle GM; Piper M; Smith AG EBioMedicine; 2017 Feb; 16():63-75. PubMed ID: 28119061 [TBL] [Abstract][Full Text] [Related]
9. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells. Vlčková K; Vachtenheim J; Réda J; Horák P; Ondrušová L J Cell Mol Med; 2018 Apr; 22(4):2240-2251. PubMed ID: 29369499 [TBL] [Abstract][Full Text] [Related]
10. BRN2 is a non-canonical melanoma tumor-suppressor. Hamm M; Sohier P; Petit V; Raymond JH; Delmas V; Le Coz M; Gesbert F; Kenny C; Aktary Z; Pouteaux M; Rambow F; Sarasin A; Charoenchon N; Bellacosa A; Sanchez-Del-Campo L; Mosteo L; Lauss M; Meijer D; Steingrimsson E; Jönsson GB; Cornell RA; Davidson I; Goding CR; Larue L Nat Commun; 2021 Jun; 12(1):3707. PubMed ID: 34140478 [TBL] [Abstract][Full Text] [Related]
11. A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITF Smith MP; Rana S; Ferguson J; Rowling EJ; Flaherty KT; Wargo JA; Marais R; Wellbrock C Pigment Cell Melanoma Res; 2019 Mar; 32(2):280-291. PubMed ID: 30277012 [TBL] [Abstract][Full Text] [Related]
14. PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression. He S; Li CG; Slobbe L; Glover A; Marshall E; Baguley BC; Eccles MR Melanoma Res; 2011 Feb; 21(1):24-34. PubMed ID: 21164369 [TBL] [Abstract][Full Text] [Related]
15. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Strub T; Giuliano S; Ye T; Bonet C; Keime C; Kobi D; Le Gras S; Cormont M; Ballotti R; Bertolotto C; Davidson I Oncogene; 2011 May; 30(20):2319-32. PubMed ID: 21258399 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells. Cheli Y; Giuliano S; Fenouille N; Allegra M; Hofman V; Hofman P; Bahadoran P; Lacour JP; Tartare-Deckert S; Bertolotto C; Ballotti R Oncogene; 2012 May; 31(19):2461-70. PubMed ID: 21996743 [TBL] [Abstract][Full Text] [Related]
17. MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2. Luo C; Merz PR; Chen Y; Dickes E; Pscherer A; Schadendorf D; Eichmüller SB Cancer Lett; 2013 Dec; 341(2):240-7. PubMed ID: 23962556 [TBL] [Abstract][Full Text] [Related]
18. Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas. Dynek JN; Chan SM; Liu J; Zha J; Fairbrother WJ; Vucic D Cancer Res; 2008 May; 68(9):3124-32. PubMed ID: 18451137 [TBL] [Abstract][Full Text] [Related]
19. SOX5 is involved in balanced MITF regulation in human melanoma cells. Kordaß T; Weber CE; Oswald M; Ast V; Bernhardt M; Novak D; Utikal J; Eichmüller SB; König R BMC Med Genomics; 2016 Feb; 9():10. PubMed ID: 26927636 [TBL] [Abstract][Full Text] [Related]
20. NFATc2 is an intrinsic regulator of melanoma dedifferentiation. Perotti V; Baldassari P; Molla A; Vegetti C; Bersani I; Maurichi A; Santinami M; Anichini A; Mortarini R Oncogene; 2016 Jun; 35(22):2862-72. PubMed ID: 26387540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]